STING1 and neoplasm: Moreover, Luo et al. identified NLRX1 as a critical intermediary partner to facilitate HPV16 E7-potentiated STING turnover and the depletion of NLRX1 resulted in significantly improved IFN-I-dependent T-cell infiltration profiles and tumor control [111].